Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2017
Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck CancerAsel Biktasova, Michael Hajek, Andrew Sewell, et al.
The Laryngoscope|August 29, 2018
Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell CarcinomaShayan Cheraghlou, Amy Schettino, Cheryl K Zogg, et al.
Head & Neck|November 4, 2009
Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapyAarti Bhatia, Archana Rao, Kie-Kian Ang, et al.
Anticancer Research|September 15, 2019
Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant TherapyGokoulakrichenane Loganadane, Benjamin H Kann, Henry S Park, et al.
Head & Neck|April 1, 2025
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckAarti Bhatia, Ranee Mehra, Jessica Bauman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2023
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck CancerJulie E Bauman, Nabil F Saba, Denise Roe, et al.
Future Oncology (London, England)|October 15, 2025
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumorsThomas Powles, Aarti Bhatia, Barbara Burtness, et al.
Oral Oncology|November 23, 2025
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 studyKevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, et al.
Cancer|March 13, 2026
A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)Aarti Bhatia, Zhengjia Chen, Yuji Zhang, et al.
Pageof 2